REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/23/2025
Back to search
Official data from USPTO
BOOSTRIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
06/24/2025
Trademark type
Combined
Nice classes
5
Filing date
08/27/2019
Registration date
06/23/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/23/2020
Last transaction
06/24/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
33
Owner location
BE
Examiner
DWYER, JOHN
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the literal element "BOOSTRIX" in purple with a green three leaf clover design to the upper right.
Holders and representatives
Holders
GlaxoSmithKline Biologicals S.A.
Representatives
Christopher M. Hanes GSK
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines for human use
Publications
History of USPTO decisions and trademark events.
27 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/30/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/02/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/02/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/02/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/02/2022
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
11/02/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/10/2020
FIMP
FINAL DISPOSITION PROCESSED
10/10/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/23/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
06/23/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/07/2020
PUBO
PUBLISHED FOR OPPOSITION
04/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/18/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/29/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/28/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/28/2020
RFNT
REFUSAL PROCESSED BY IB
01/24/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/07/2020
RFRR
REFUSAL PROCESSED BY MPU
01/07/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/05/2019
CNRT
NON-FINAL ACTION WRITTEN
12/04/2019
DOCK
ASSIGNED TO EXAMINER
11/27/2019
MAFR
APPLICATION FILING RECEIPT MAILED
10/22/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/18/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/17/2019
Continuous trademark protection
Get notified about every new filing that threatens BOOSTRIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.